Mural Oncology PLC (MURA)
(Delayed Data from NSDQ)
$3.15 USD
-0.02 (-0.63%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $3.14 -0.01 (-0.32%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Price, Consensus and EPS Surprise
MURA 3.15 -0.02(-0.63%)
Will MURA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MURA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for MURA
MURA Stock Earnings: Mural Oncology Beats EPS for Q2 2024
Mural Oncology plc GAAP EPS of -$1.86
Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress
Mural Oncology reports Q2 EPS ($1.86) vs ($3.01) last year
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)